LINC00052 inhibits tumor growth, invasion and metastasis by repressing STAT3 in cervical carcinoma.

Lin J, Nong LL, Li MQ, Yang FC, Wang SH, Liu MJ.

Open source

DOI
10.26355/eurrev_201906_18047
Published
2019-06-01
Container
Eur Rev Med Pharmacol Sci
Publisher
Not recorded
Open access
no

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.26355/eurrev_201906_18047,
  title = {LINC00052 inhibits tumor growth, invasion and metastasis by repressing STAT3 in cervical carcinoma.},
  author = {Lin J and  Nong LL and  Li MQ and  Yang FC and  Wang SH and  Liu MJ.},
  year = {2019},
  journal = {Eur Rev Med Pharmacol Sci},
  doi = {10.26355/eurrev_201906_18047},
  url = {https://doi.org/10.26355/eurrev_201906_18047}
}

RIS

TY  - JOUR
TI  - LINC00052 inhibits tumor growth, invasion and metastasis by repressing STAT3 in cervical carcinoma.
AU  - Lin J
AU  -  Nong LL
AU  -  Li MQ
AU  -  Yang FC
AU  -  Wang SH
AU  -  Liu MJ.
PY  - 2019
JO  - Eur Rev Med Pharmacol Sci
DO  - 10.26355/eurrev_201906_18047
UR  - https://doi.org/10.26355/eurrev_201906_18047
ER  - 

APA

J, L., LL, N., MQ, L., FC, Y., SH, W., & MJ., L. (2019). LINC00052 inhibits tumor growth, invasion and metastasis by repressing STAT3 in cervical carcinoma.. Eur Rev Med Pharmacol Sci. https://doi.org/10.26355/eurrev_201906_18047

Source records